Microdialysis
in behaving animals was used to concomitantly characterize the dopamine and 5-HT responses in the caudate and the norepinephrine response in the hippocampus to the D-and L-isomers of amphetamine and methamphetamine. Doses of all four drugs which promoted similar stereotypy responses produced a D-amphetamine-like response profile of dopamine and dopamine metabolites, suggesting that all these drugs interact with dopamine systems to facilitate the release of transmitter.
However, in contrast to the similar behavioral profiles, the magnitude of the dopamine responses diverged significantly. In addition, all four drugs increased extracellular norepinephrine and SHT, but the relative responses differed markedly from dopamine and from each other. The contrasting structure-activity relationships for these drugs likely reflect their differential potency at the various neuronal uptake transporters in promoting either transmitter release, and/or uptake blockade. In addition, the interaction of each drug at the vesicular transporters, as well as the availability of a cytoplasmic pool of transmitter likely also contribute to the neurotransmitter response.
Because of the particularly divergent transmitter response profiles exhibited by L-methamphetamine, its behavioral and neurotransmitter effects were characterized over a more extended range of doses. Although the duration of the increase in extracellular dopamine was clearly proportional to dose, the dose-dependent increases in the magnitude of the dopamine response did not parallel the behavioral profiles. The results of these studies indicate that, while the dopamine, norepinephrine and 5-HT responses to these drugs probably contribute to the expression of stimulant-induced behaviors, simple relationships between the neurotransmitter responses and the behavioral profiles were not evident. [Key words: microdialysis, caudate, hippocampus, dopamine, norepinephrine, amphetamine, methamphetamine, stereoisomers, stereotypy] Mesolimbic and mesostriatal dopamine (DA) pathways are crucial components in the motor activating effects ofamphetaminelike stimulants (Creese and Iversen, 1974; Kelly, 1977; Cole, 1978; Sessions et al., 1980) . However, the stimulant-induced behavioral response profile does not correspond closely to the quantitative characteristics of the caudate and accumbens DA responses Kuczenski et al., 199 1) . This and a variety of other observations (see Segal and Kuczenski, 1994 , for a review) suggest that other neurotransmitter systems must contribute significantly to the behavioral effects of these drugs.
The microdialysis technique provides a methodology with which to evaluate the relative contribution of multiple neurotransmitter systems in various brain regions to the features of the drug-induced behavioral response in the same animal. Therefore, in the present studies, we have extended our earlier characterizations of the neurotransmitter responses to amphetamine (AMPH) Kuczenski et al., 1991; Florin et al., 1992; Kuczenski and Segal, 1992a) by concomitantly evaluating caudate DA and serotonin (5-HT), and hippocampus norepinephrine (NE). In addition, we have broadened the scope of these studies to include L-AMPH, and D-, and L-methamphetamine (METH) for comparison with D-AMPH. All of these drugs promote qualitatively similar behavioral responses, but they exhibit different potencies in their interactions with the various biogenic amine transporters (Heikkila et al., 1975; Fischer and Cho, 1979; Andersen, 1987 Andersen, , 1989 Krueger, 1990; Zaczek et al., 1991) , and this variation in potency has been implicated in their ability to alter synaptic transmitter dynamics. We reasoned, therefore, that a comparison of the relative efficacies of these AMPH derivatives to enhance the extracellular concentrations of DA, 5-HT, and NE would provide insight into the roles of these transmitter pathways in the various behavioral components of the psychostimulant response.
Materials and Methods
Rats obtained from Harlan Laboratories (275-300 gm) were maintained four/cage on a 14 hr/lO hr light-dark cycle (lights on at 05:OO) under standard laboratory conditions, with ad libitum access to food and water for 2 weeks prior to drug treatment. Animals were then stereotaxically implanted with guide cannulae using procedures previously described in detail . Guide cannulae extended 2.6 mm below the surface of the skull and were aimed at the caudate (1.0 mm anterior to bregma, 2.8 mm lateral, and 6.2 mm below dura) and the hippocampus (5.8 mm posterior, 4.8 mm lateral, 7.5 mm below dura). Following surgery, animals were housed individually and allowed at least 1 week to recover before receiving any treatment. Each rat was placed in an experimental chamber and the dialysis probes were inserted on the day prior to treatment (3:00 to 4:00 P.M.) to allow for acclimation to the test environment and for adequate equilibration of the dialysis probes. Concentric microdialysis probes were MINUTES constructed of Spectra/Par hollow fiber (MW cut-off 6000, o.d. 250~) as previously described . The length of the active probe membrane was 3 mm. Probes were perfused with artificial cerebrospinal fluid (147 mM NaCI, 1.2 mM CaCl,, 0.9 mM MgCI,, 4.0 mM KCl) delivered bv a microinfusion pump (2 Ml/mitt) via 50 cm of Micro-line ethyl vinyl acetate tubing connected to a fluid swivel. Dialysate was collected through glass capillary tubing into vials containing 20 ~1 of 25% methanol, 0.2 M sodium citrate, pH 3.8. Under these conditions, dialysate DA, 5-HT, NE, and metabolites were stable throughout the collection and analysis interval. Samples were collected outside the experimental chamber to avoid disturbing the animal. Individual probe recoveries, which ranged from 5% to 9Oh, were estimated by sampling a standard DA solution in v&-o. Preliminary studies indicated that individual probe recoveries for DA, 5-HT, and NE were similar.
The behavioral chambers, described in detail elsewhere (Segal and Kuczenski, 1987; Kuczenski and Segal, 1989) were sound-proofed, and were maintained on a 14 hr/lO hr light-dark cycle (lights on at 5 A.M.), with constant temperature and humidity. Animals had continuous access to food and water. Behavioral measures were recorded automatically using computer-assisted techniques and each animal was videotaped for observational rating as previously described (Segal and Kuczenski, 1987) . At the end of the experiment, each animal was perfused with formalin for histological verificatton of probe placements.
Dialvsate samples (40 ~1) were collected every 20 mitt, and DA, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 3-methoxvtvramine (3MT). 5-hvdroxvindoleacetic acid (HIAA), and serotonin'(i-HT) in caudate samples; or for norepineph'rine (NE) in hippocampus were assayed by HPLC with electrochemical detection (HPLC-EC). In all experiments, solutions of standards revealed a clean separation between 3MT and 5-HT. Each HPLC-EC consisted of a 100 mm x 4.6 mm ODS-Cl8 3p column (Regis) maintained at 40°C for DA/S-HT assays, or at 30°C for NE assays. Mobile phase (0.06 M citric acid, 7% methanol, 0.1 mM Na,EDTA, and 0.2 mM octane sulfonate adjusted to pH 4.0-4.5, for DPU'S-HT; 4% methanol and 1.5 mM octane sulfonate for NE) was delivered at 0.6 ml/min by a Waters model 5 10 pump. Amines were detected with Waters 460 detectors with glassy carbon electrodes maintained at + 0.65 V relative to a Ag/AgCl reference electrode. The quantitation limits for DA, 5-HT, and NE were near 2-3 fmol. Concentrations were estimated from peak areas using a Waters and L-METH (n = 6) of animals undergoing concomitant caudate and hippocampus dialysis. Stereotypy is presented as percentage of total time spent in repetitive movements (mean + SEM). Histograms represent the cumulated response over the indicated interval. ANOVA indicated no significant treatment effect.
Maxima 820 data station. Substances in the dialysates were corrected for individual probe recoveries to account for this source of variability, and, although the exact relationship between dialysate concentration and actual extracellular transmitter content is not clear (Wages et al., 1986; Church and Justice, 1987; Benveniste et al., 1989; Stahle et al., 199 I) , values are presented as corrected dialysate concentration and referred to as extracellular concentration to allow for meaningful comparisons to other data in the literature. Drug-induced neurochemical and behavioral effects were statistically evaluated using one-or twoway repeated measures ANOVA. Group/time comparisons were made using t tests with Bonferroni corrections. Both stereoisomers ofAMPH and D-METH were obtained from NIDA. L-METH was synthesized according to Kishi et al. (1983) . Briefly, D-ephedrine (Aldrich Chemical Co., Milwaukee WI) was converted to its chloro derivative with thionyl chloride in benzene. The crude chloride was hydrogenated over 10% palladium on carbon for 48 hr, the mixture was filtered, and the product was isolated by evaporation. Recrystallization from methanol/ether yielded crystals of the hydrochloride whose purity was checked by GC/MS and NMR spectrometry. The enantiomeric purity was evaluated by derivitizing with N-TFA-L-prolylchloride (Regis Chem Co., Morton Grove, IL) and found to be 97.5% and 98.7Oh in two separate analyses. All drugs were dissolved in saline and were administered subcutaneously in a volume of 1 mVkg body weight at about IO:00 A.M. Doses refer to the free base.
Results
Basal caudate extracellular concentrations of DA, its metabolites, DOPAC, HVA, and 3MT, and of 5-HT and its metabolite, HIAA, as well as of hippocampus extracellular NE, are summarized in Table 1 . These values are similar to earlier results. It should be noted, however, that basal extracellular 5-HT and NE concentrations are low (Kalen et al., 1988 (Kalen et al., , 1989 Abercrombie and Zigmond, 1989; Adell et al., 1989; Globus et al., 1989; Pei et al., 1989; Van Veldhuizen et al., 1990) and in the present experiments were near the limits of assay sensitivity.
Based on our previous results, doses of the D-and L-isomers of AMPH and METH which promoted similar stereotypy re- sponse patterns were selected for subsequent dialysis studies. The stereotypy responses of dialyzed rats following administration of these doses are presented in Figure 1 . All groups exhibited predominantly repetitive head and limb movements, and ANO-VA revealed no significant group differences. The D-METH group also engaged in some oral behaviors. In response to D-and L-AMPH, and D-METH, this dose range elicited multiphasic locomotor response profiles (data not shown), in which the prolonged period of focussed stereotypies was associated with the absence of ambulation. In contrast, following L-METH, most animals continued to ambulate, interrupted by episodes of intense stereotypies. The caudate DA response patterns for these animals are presented in Figure 2 . Consistent with our past results, in response to 2 mg/kg D-AMPH, mean caudate extracellular DA increased approximately 15-fold to a peak concentration of 688 ? 121 nM during the initial 20 min interval, then returned to baseline over the next 3 hr. Similarly, in response to 2 mg/kg D-METH, DA increased to a peak concentration of 648 f 71 nM during the initial 20 min interval and then declined toward baseline. In contrast, in response to both 6 mg/kg L-AMPH and 12 mg/ kg L-METH, peak DA concentrations (508 -t 5 1 and 287 & 49 nM, respectively) were delayed to the second 20 min interval, before returning toward baseline. During the initial 20 min interval, the responses to both D-isomers were significantly higher than the responses to both L-isomers. In addition, the peak responses to both D-AMPH and D-METH were significantly higher than the peak response to L-METH.
Following injection of each AMPH derivative, the DA metabolites, DOPAC and HVA, exhibited responses typical of D-AMPH. Repeated measures ANOVA revealed significant changes over time for both measures (Fig. 3) , and a significant time x group interaction for HVA. All four drugs also significantly increased extracellular 3MT concentrations (Fig. 4) , but there were no significant group effects, nor time x group interactions.
The responses of caudate 5-HT to the four AMPH derivatives are presented in Figure 5 . All four drugs increased extracellular 5-HT. However, in contrast to what was observed for caudate DA, both stereoisomers of METH promoted similar and significantly higher peak 5-HT concentrations than either stereoisomer of AMPH (Fig. 5, histograms) . Caudate HIAA concentrations were stable throughout the experiment, and no significant drug effects were observed (data not shown).
All four drugs also increased hippocampal NE concentrations (Fig. 6 ). Similar to our previous results, 2 mg/kg D-AMPH increased NE to a maximum of 29.3 f 3.1 nM, about 20-fold over baseline, during the second 20 min interval. L-AMPH (6 mg/ kg) produced a comparable effect, increasing NE concentrations to 32.0 f 8.9 nM. In contrast, D-METH promoted an increase in NE to 12.0 f 1.2 nM which was significantly lower than all other groups, whereas L-METH promoted an increase to 64.8 f 4.9 nM, which was significantly higher than all other groups. Maximal NE concentrations and cumulative responses are summarized in Figure 6 (histograms).
Because of the particularly divergent transmitter response profiles exhibited by L-METH, (i.e., this drug promoted the lowest DA response, but the highest NE response; see Figs. 2, 6), we further examined its behavioral and neurotransmitter effects over a more extended range of doses (3-18 mg/kg), and the results are summarized in Figures 7-10 . All doses promoted locomotor activation which was interrupted by progressively longer episodes of repetitive head movements as the dose was increased (Fig. 7) . No dose resulted in a continuous phase of Values are dialysate concentrations (no) corrected for individual probe recoveries, and are presented as means f SEM; n = 47 for caudate DA and metabolites; n = 42 for caudate 5-HT, n = 49 for hippocampus NE.
focussed stereotypies in the absences of locomotion, or in the appearance of oral stereotypies. The temporal pattern of caudate extracellular DA as a function of dose of L-METH is presented in Figure 8 . The duration of the increase in extracellular DA was clearly proportional to dose. However, the maximal increases in caudate DA at the three higher doses were all significantly greater than at 3 mg/ kg, but not significantly different from each other (Fig. 8) . Increasing the dose of L-METH produced AMPH-like effects on caudate DA metabolites (data not shown), including dose-related decreases in DOPAC and HVA concentrations and increases in 3MT which were dose-dependent in both magnitude and duration.
Both caudate 5-HT (Fig. 9 ) and hippocampal NE (Fig. 10 ) were increased by L-METH, and the increases were dose-dependent both in magnitude and duration. In each case, however, maximal increases following 12 and 18 mg/kg L-METH were identical.
Discussion
The results of this study indicate that the stereoisomers of AMPH and METH can promote similar behavioral effects which are associated with markedly different DA, NE, and 5-HT responses. Most evidence suggests that the AMPH derivatives alter biogenic amine function by their interactions with the transmitter uptake process. Thus, the contrasting structure-activity relationships for these drugs likely reflect their differential potency at each transmitter uptake transporter.
With regard to the effects of these drugs on DA, our results indicate that D-AMPH and D-METH promoted equivalent increases in extracellular DA, whereas the responses to the two L-isomers were lower. In general, these results are consistent with previous in vitro studies which indicated that D-AMPH and D-METH are about equipotent in their abilities to release DA (Fischer and Cho, 1979) or inhibit its uptake (Krueger, 1990) , and that D-and L-AMPH exhibit a three-to sevenfold difference in potency at the DA transporter (Heikkila et al., 1975; Fischer and Cho, 1979; Andersen, 1987 Andersen, , 1989 Zaczek et al., 199 1) . Relative potencies of L-METH are not available.
The AMPH derivatives produced NE and S-HT response patterns that were distinct from DA and from each other. Thus, whereas D-METH was relatively potent in increasing caudate DA, it produced the smallest increase in hippocampal NE. In contrast, L-METH promoted the smallest increase in caudate DA, but the greatest increase in hippocampal NE, and D-and L-AMPH were approximately equipotent in increasing NE at doses that produced significantly different DA responses. At the same time, the relative potency pattern for 5-HT was substantially different than for both catecholamines. Thus, whereas both that is, maximal extracellular DA concentrations were achieved It is likely that these different neurotransmitter response patfollowing the 6 mg/kg dose (Fig. 8) , whereas this dose increased terns reflect the drugs' interactions at the various transporters, extracellular 5-HT less than half-maximally relative to the highresulting in either carrier-mediated release, and/or uptake blocker doses (Fig. 9) .
ade. The nature of this interaction has only been well established for AMPH at the DA nerve terminal (see Kuczenski and Segal, to DA, the DA metabolite profiles for all the drugs are more 1994, for a recent review). However, previous observations, as consistent with a D-AMPH-like release process rather than with well as the present data, provide some insight into the actions uptake blockade. We have previously shown that DA uptake ofthese drugs at the three neurotransmitter systems. or HVA concentrations (Kuczenski et al., 199 1; Kuczenski and Segal, 1992b) , whereas D-AMPH profoundly decreases the concentration of these metabolites (Zetterstrom et al., 1983; Zetterstrom et al., 1986; Kuczenski and Segal, 1989, 1992b; Pehek et al., 1990) . In the present studies, all the drugs promoted D-AMPH-like DA metabolite response profiles (Fig. 3) . It is unlikely that the decline in metabolites reflects AMPH inhibition of monoamine oxidase, since most evidence suggests that such an effect occurs only at relatively high AMPH concentrations (Green and El Hait, 1980; Miller et al., 1980) . Although the exact mechanism underlying the decreases in DOPAC and HVA is not fully understood, it does appear to differentiate stimulants that are DA releasers from DA uptake blockers. Other evidence also suggests that L-AMPH (Heikkila et al., 1975; Fischer and Cho, 1979) and D-METH (Fischer and Cho, 1979) can act as DA releasers. Nevertheless, although the metabolite data are parsimonious with a release mechanism, a prominent role for uptake blockade in the action of these AMPH derivatives cannot be ruled out at the present time. Some evidence suggests that 5-HT may also be released via a carrier-mediated process. Thus, using the synaptosome superfusion technique, Raiteri et al. (1975) reported that D-AMPH releases 5-HT. Subsequently, a variety of substituted AMPHs, including D-METH, have been shown to release 5-HT, and this release could be blocked by 5-HT uptake blockers (Berger et al., 1992; Rudnick and Wall, 1992; Sabol et al., 1992) consistent with a carrier-mediated mechanism.
With regard to NE, whether AMPH interacts with the brain NE transporter solely as an uptake blocker, or to also facilitate NE release has not been firmly established, since in vitro efforts to detect AMPH-induced NE release have been mixed (Heikkila et al., 1975; Kalisker et al., 1975; Raiteri et al., 1975; Rutledge, 1978) . However, we have recently shown that, although at low doses, AMPH appears to act primarily as an uptake blocker, as the dose is increased into the range used in the present studies, NE release predominates (Florin et al., 1994) . Based on these data, we have speculated (Kuczenski, 1983; Florin et al., 1994) as have others with regard to the sympathetic nervous system (Trendelenburg, 199 l) , that a releasing action by AMPH requires mobilization of vesicular NE into the cytoplasm, and several mechanisms have been postulated by which AMPH, particularly at higher doses, can produce NE mobilization (Johnson et al., 1982; Phillips, 1982; Sulzer and Rayport, 1990) . In this regard, AMPH exhibits a lower IC,, in its interaction with the neuronal transporter than with the vesicular transporter (Schumann and Philippu, 1962; Philippu and Beyer, 1973; Ferris and Tang, 1979; Knepper et al., 1988) . Thus, AMPH would be expected to effectively inhibit NE uptake at lower doses than required to mobilize vesicular NE for release.
In vitro, D-AMPH and L-AMPH are equipotent as inhibitors of NE uptake into the nerve terminal (Heikkila et al., 1975; Andersen, 1989) and, if uptake blockade predominated at the doses used in the present studies, these isomers should produce comparable increases in extracellular NE. However, our in vivo results (Fig. 6) suggest that the D-isomer is significantly more potent than the L-isomer in increasing extracellular NE. In this regard, D-AMPH is IO-fold more potent than L-AMPH in interacting with the vesicular NE transporter (Ferris and Tang, 1979) and therefore, at equipotent uptake blocking doses, d-AMPH might be expected to disrupt vesicular stores of NE to a greater extent than L-AMPH. Thus, our results may be explained by the fact that D-AMPH increases cytoplasmic transmitter to a greater extent. Furthermore, the extremely high levels of extracellular NE observed following 12-l 8 mg/kg L-METH et al. In summary, in considering the mechanisms which contribute to the relative response patterns of the three biogenic amines to the AMPH derivatives, the potency of each drug at both the neuronal and vesicular transporters, as well as the availability of a cytoplasmic pool of transmitter must be considered. Although these drugs are potent uptake blockers at the DA and S-HT neuronal transporters, the cytoplasmic localization of the enzymes required for DA and 5-HT synthesis may permit sufficient accumulation of cytoplasmic transmitter to sustain release through a carrier-mediated process. In contrast, in the absence of a cytoplasmic NE pool, low doses of the AMPH derivatives act predominantly as uptake blockers at the neuronal transporter.
However, as the dose is increased, the AMPH derivatives can accumulate in the cytoplasm to sufficiently high concentrations to disrupt vesicular storage, thus facilitating transmitter release from all three biogenic amine nerve terminals.
We have previously described the profound dissociation which occurs between the quantitative features of the behavioral and caudate and accumbens DA responses to psychomotor stimulants under a variety of conditions (Callaway et al., 1989; Segal and Kuczenski, 1992; Kuczenski et al., 1990, 199 l) , and the present results further support this observation. First, whereas the AMPH derivatives generally produced qualitatively and quantitatively similar stereotypy profiles, the magnitude of the caudate DA responses diverged significantly. Second, although the cumulated caudate DA and stereotypy responses to L-METH exhibited parallel dose response characteristics, this relationship appears to reflect the dose-dependent duration of the effects, and, in fact, the early period of stereotypy (Fig. 7) did not parallel the initial or maximal DA responses (Fig. 8) .
It should be noted, however, that, in contrast to the marked differences in the caudate DA responses to the AMPH derivatives at behaviorally similar doses, these drugs produced comparable 3MT responses (Fig. 4) . We have previously noted that extracellular concentrations of 3MT and DA appear to reflect different aspects of synaptic DA dynamics and have suggested that 3MT might represent an alternative index of receptor-relevant DA concentrations (Kuczenski and Segal, 1992b) . Our results are consistent with this hypothesis, and suggest that a further examination of DA-3MT-behavior relationships is warranted. However, it is important to note that, as with extracellular DA, the 3MT response (Fig. 4) is temporally dissociated from the behavioral response (Fig. 1) . Therefore, caudate DA function alone cannot account for the stimulant behavioral profile. That AMPH and its derivatives increased extracellular concentrations of NE and 5-HT, as well as DA, is consistent with this proposal. However, the behavioral responses to these drugs were similar at doses which produced markedly different effects on all three neurotransmitters.
Therefore, an understanding of the contribution of these various effects of AMPH to the behavioral response will require further study. In summary, the four AMPH derivatives all increase extracellular concentrations of DA and S-HT in the caudate and NE in the hippocampus.
However, their neurotransmitter response patterns diverged considerably. This range of response patterns may be due to differential interactions of these drugs with the biogenic amine transporters. Although it is likely that all these transmitter responses contribute to the expression of stimulantinduced behaviors, additional studies will be required to more accurately define their specific roles.
